A Study to Assess the Effectiveness and Safety of Ozanimod in Chinese Adults With Relapsing Multiple Sclerosis
Clinical trial NCT06396039 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06396039
- Sponsor
- Bristol-Myers Squibb
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2024-05-15
- Primary completion
- 2028-12-29
- Enrollment
- 84
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.